Search alternatives:
significantly slight » significantly lighter (Expand Search), significantly high (Expand Search), significantly higher (Expand Search)
slight decrease » slight increase (Expand Search)
significantly a » significantly _ (Expand Search), significantly i (Expand Search), significantly vary (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 81 - 100 results of 74,306 for search '(( significantly slight decrease ) OR ( significantly a decrease ))', query time: 3.41s Refine Results
  1. 81
    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 82
    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 83
    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 84
    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific.

    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 85
    Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines.

    Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines. by Nazima Nasrullah (6874496)

    Published 2023
    “…<p>Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines.…”
    Save to List
    Saved in:
  6. 86
    Fig 4 -

    Fig 4 - by Huangpan He (18121617)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 87
    Fig 2 -

    Fig 2 - by Huangpan He (18121617)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 88
    Fig 3 -

    Fig 3 - by Huangpan He (18121617)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 89
    Changes in moisture content and germination of <i>Phoebe chekiangensis</i> seeds during desiccation.

    Changes in moisture content and germination of <i>Phoebe chekiangensis</i> seeds during desiccation. by Huangpan He (18121617)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 90
    Correlation analysis between physiological and biochemical indexes during seed desiccation.

    Correlation analysis between physiological and biochemical indexes during seed desiccation. by Huangpan He (18121617)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 91
    The relationship between the use of PPI and the 12 upper gastrointestinal symptoms by FSSG.

    The relationship between the use of PPI and the 12 upper gastrointestinal symptoms by FSSG. by Nobutake Yamamichi (381131)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 92
    Trend in PPI and H<sub>2</sub>RA uses from 2010 to 2019 in Japan.

    Trend in PPI and H<sub>2</sub>RA uses from 2010 to 2019 in Japan. by Nobutake Yamamichi (381131)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 93
    Fig 11 -

    Fig 11 - by Naveed Arshad (19712985)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 94
    Fig 9 -

    Fig 9 - by Naveed Arshad (19712985)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 95
    Fig 10 -

    Fig 10 - by Naveed Arshad (19712985)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 96
    DDC for four anticoagulants from 2019 to 2023.

    DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 97
    Inpatient utilization of anticoagulants from 2019 to 2023.

    Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 98
    Outpatient utilization of anticoagulants from 2019 to 2023.

    Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 99
    Utilization of anticoagulants from 2019 to 2023.

    Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 100
    The expenditure on anticoagulants in the period of 2019-2023(million CNY).

    The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: